Know Your Options (Strategies)
Whether you are looking for simplicity, to protect current positions in your portfolio, or to make money on stocks you already own, here are some… Read More »Know Your Options (Strategies)
Whether you are looking for simplicity, to protect current positions in your portfolio, or to make money on stocks you already own, here are some… Read More »Know Your Options (Strategies)
There’s a divergence occurring between actual equity performance and stock volatility. With investor expectations of volatility remaining high (especially ahead of the midterm elections), here… Read More »Pre-Midterm Jitter Trades
Traders looking for greater consistency in their results could take a page from pilots’ use of pre-flight checklists and employ a pre-trade checklist. Here are… Read More »Creating A Simple Pre-Trade Checklist
With the trading season for cannabis stocks kicking off in the fall, and most cannabis stocks expected to hit their all-time highs in December and… Read More »A Time For Pot – And Profit Taking?
While the prevailing narrative is that men are bigger risk takers with their investments, data from one investment app suggests that, in actuality, men and… Read More »Men, Women, Investing & Risk: There’s An App (Study) For That!
With a growing body of evidence showing that investing with an eye on environmental, social and governance (ESG) factors doesn’t require sacrificing returns (and may… Read More »Where To Find A Good Guy (Stock)
After experiencing a drying up of inflows for much of this year, this marijuana ETF was the top-performing ETF of August. Here are the factors… Read More »Pot On Top
There are very few diseases for which actual cures have been developed – but that could soon start to change. And with a “golden age… Read More »The New Paradigm For Biotech Investing
Which trading style is the best fit for you? Here’s a look at the four main trading styles – position trading, swing trading, day trading… Read More »Find Your Trading Style
The research team at Bank of America Merrill Lynch sees big upside potential for Big Pharma in the remaining months of 2018. Here are some… Read More »Big Upside Potential In Big Pharma